In addition to synapse alterations occurring in ocular diseases, they also play a decisive role in other diseases, especially in relation to Alzheimer’s disease [74,75,76,77], as reduced levels of VGluT1 heighten beta amyloid-induced neuroinflammation and affect synaptic plasticity [78]. Here, SLC17A7 is linked to Alzheimer disease.